Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
501-1,000 employees
-
Headquarters
-
Exton, PA
-
Type
-
Public Company
-
Specialties
-
A full service Preclinical CRO, Pharmacokenetics, Bioavailability, Metabolite ID and Production, Drug Transporters, Organ Perfusion, Tissue Permeability, Metabolism, Drug Discovery Screening, Medical Device Testing, Ocular Studies, IND- and NDA- Enabling, Biologics, Potency Assays, Small Molecules, Large Molecules, Cell & Gene Therapy, Formulations, In Vitro Dissolution Absorption Systems, BCS, Dermal, In Vitro, In Vivo, Ex Vivo, and ADME